BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12846415)

  • 1. Growth and fatty acid metabolism of human breast cancer (MCF-7) xenografts in nude rats: impact of constant light-induced nocturnal melatonin suppression.
    Blask DE; Dauchy RT; Sauer LA; Krause JA; Brainard GC
    Breast Cancer Res Treat; 2003 Jun; 79(3):313-20. PubMed ID: 12846415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circadian stage-dependent inhibition of human breast cancer metabolism and growth by the nocturnal melatonin signal: consequences of its disruption by light at night in rats and women.
    Blask DE; Dauchy RT; Brainard GC; Hanifin JP
    Integr Cancer Ther; 2009 Dec; 8(4):347-53. PubMed ID: 20042410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin inhibition of cancer growth in vivo involves suppression of tumor fatty acid metabolism via melatonin receptor-mediated signal transduction events.
    Blask DE; Sauer LA; Dauchy RT; Holowachuk EW; Ruhoff MS; Kopff HS
    Cancer Res; 1999 Sep; 59(18):4693-701. PubMed ID: 10493527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Light during darkness, melatonin suppression and cancer progression.
    Blask DE; Dauchy RT; Sauer LA; Krause JA; Brainard GC
    Neuro Endocrinol Lett; 2002 Jul; 23 Suppl 2():52-6. PubMed ID: 12163849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats.
    Blask DE; Brainard GC; Dauchy RT; Hanifin JP; Davidson LK; Krause JA; Sauer LA; Rivera-Bermudez MA; Dubocovich ML; Jasser SA; Lynch DT; Rollag MD; Zalatan F
    Cancer Res; 2005 Dec; 65(23):11174-84. PubMed ID: 16322268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antineoplastic effects of melatonin on a rare malignancy of mesenchymal origin: melatonin receptor-mediated inhibition of signal transduction, linoleic acid metabolism and growth in tissue-isolated human leiomyosarcoma xenografts.
    Dauchy RT; Blask DE; Dauchy EM; Davidson LK; Tirrell PC; Greene MW; Tirrell RP; Hill CR; Sauer LA
    J Pineal Res; 2009 Aug; 47(1):32-42. PubMed ID: 19486272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lighting for the human circadian clock: recent research indicates that lighting has become a public health issue.
    Pauley SM
    Med Hypotheses; 2004; 63(4):588-96. PubMed ID: 15325001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Light contamination during the dark phase in "photoperiodically controlled" animal rooms: effect on tumor growth and metabolism in rats.
    Dauchy RT; Sauer LA; Blask DE; Vaughan GM
    Lab Anim Sci; 1997 Oct; 47(5):511-8. PubMed ID: 9355094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic inhibition of the tumor suppressor ARHI by light at night-induced circadian melatonin disruption mediates STAT3-driven paclitaxel resistance in breast cancer.
    Xiang S; Dauchy RT; Hoffman AE; Pointer D; Frasch T; Blask DE; Hill SM
    J Pineal Res; 2019 Sep; 67(2):e12586. PubMed ID: 31077613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Putting cancer to sleep at night: the neuroendocrine/circadian melatonin signal.
    Blask DE; Dauchy RT; Sauer LA
    Endocrine; 2005 Jul; 27(2):179-88. PubMed ID: 16217131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doxorubicin resistance in breast cancer is driven by light at night-induced disruption of the circadian melatonin signal.
    Xiang S; Dauchy RT; Hauch A; Mao L; Yuan L; Wren MA; Belancio VP; Mondal D; Frasch T; Blask DE; Hill SM
    J Pineal Res; 2015 Aug; 59(1):60-9. PubMed ID: 25857269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dim light during darkness stimulates tumor progression by enhancing tumor fatty acid uptake and metabolism.
    Dauchy RT; Blask DE; Sauer LA; Brainard GC; Krause JA
    Cancer Lett; 1999 Oct; 144(2):131-6. PubMed ID: 10529012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin uptake and growth prevention in rat hepatoma 7288CTC in response to dietary melatonin: melatonin receptor-mediated inhibition of tumor linoleic acid metabolism to the growth signaling molecule 13-hydroxyoctadecadienoic acid and the potential role of phytomelatonin.
    Blask DE; Dauchy RT; Sauer LA; Krause JA
    Carcinogenesis; 2004 Jun; 25(6):951-60. PubMed ID: 14754876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circadian regulation of molecular, dietary, and metabolic signaling mechanisms of human breast cancer growth by the nocturnal melatonin signal and the consequences of its disruption by light at night.
    Blask DE; Hill SM; Dauchy RT; Xiang S; Yuan L; Duplessis T; Mao L; Dauchy E; Sauer LA
    J Pineal Res; 2011 Oct; 51(3):259-69. PubMed ID: 21605163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New actions of melatonin on tumor metabolism and growth.
    Blask DE; Sauer LA; Dauchy R; Holowachuk EW; Ruhoff MS
    Biol Signals Recept; 1999; 8(1-2):49-55. PubMed ID: 10085462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human cancer xenograft perfusion in situ in rats: a new perfusion system that minimizes delivery time and maintains normal tissue physiology and responsiveness to growth-inhibitory agents.
    Dauchy EM; Dauchy RT; Davidson LK; Lynch DT; Krause JA; Blue LM; Sauer LA; Blask DE
    J Am Assoc Lab Anim Sci; 2006 May; 45(3):38-44. PubMed ID: 16642969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Light-at-night-induced circadian disruption, cancer and aging.
    Anisimov VN; Vinogradova IA; Panchenko AV; Popovich IG; Zabezhinski MA
    Curr Aging Sci; 2012 Dec; 5(3):170-7. PubMed ID: 23237593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential inhibition of fatty acid transport in tissue-isolated steroid receptor negative human breast cancer xenografts perfused in situ with isomers of conjugated linoleic acid.
    Dauchy RT; Dauchy EM; Sauer LA; Blask DE; Davidson LK; Krause JA; Lynch DT
    Cancer Lett; 2004 Jun; 209(1):7-15. PubMed ID: 15145516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary Melatonin and Omega-3 Fatty Acids Induce Human Cancer Xenograft Regression In Vivo in Rats by Suppressing Linoleic Acid Uptake and Metabolism.
    Dauchy EM; Dauchy RT; Tirrell RP; Davidson LK; Hill SM; Sauer LA; Blask DE
    Comp Med; 2021 Aug; 71(4):309-317. PubMed ID: 34187631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-related decline in melatonin and its MT1 receptor are associated with decreased sensitivity to melatonin and enhanced mammary tumor growth.
    Hill SM; Cheng C; Yuan L; Mao L; Jockers R; Dauchy B; Blask DE
    Curr Aging Sci; 2013 Feb; 6(1):125-33. PubMed ID: 23895529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.